nodes	percent_of_prediction	percent_of_DWPC	metapath
Potassium Canrenoate—Fluoxymesterone—breast cancer	0.54	1	CrCtD
Potassium Canrenoate—Dydrogesterone—Exemestane—breast cancer	0.0394	0.104	CrCrCtD
Potassium Canrenoate—Dydrogesterone—Fluoxymesterone—breast cancer	0.0273	0.0719	CrCrCtD
Potassium Canrenoate—Spironolactone—Fluoxymesterone—breast cancer	0.026	0.0685	CrCrCtD
Potassium Canrenoate—Megestrol acetate—Fluoxymesterone—breast cancer	0.0238	0.0627	CrCrCtD
Potassium Canrenoate—Prednisone—Exemestane—breast cancer	0.0232	0.0611	CrCrCtD
Potassium Canrenoate—Loteprednol—Exemestane—breast cancer	0.0215	0.0568	CrCrCtD
Potassium Canrenoate—Medroxyprogesterone Acetate—Fluoxymesterone—breast cancer	0.0211	0.0558	CrCrCtD
Potassium Canrenoate—Testosterone—Exemestane—breast cancer	0.0201	0.0531	CrCrCtD
Potassium Canrenoate—Prednisolone—Exemestane—breast cancer	0.0197	0.052	CrCrCtD
Potassium Canrenoate—Hydrocortamate—Fluoxymesterone—breast cancer	0.0191	0.0503	CrCrCtD
Potassium Canrenoate—Cortisone acetate—Fluoxymesterone—breast cancer	0.0185	0.0488	CrCrCtD
Potassium Canrenoate—Progesterone—Fluoxymesterone—breast cancer	0.0161	0.0424	CrCrCtD
Potassium Canrenoate—Testosterone Propionate—Fluoxymesterone—breast cancer	0.0161	0.0424	CrCrCtD
Potassium Canrenoate—Fludrocortisone—Fluoxymesterone—breast cancer	0.0161	0.0424	CrCrCtD
Potassium Canrenoate—Methyltestosterone—Fluoxymesterone—breast cancer	0.0157	0.0413	CrCrCtD
Potassium Canrenoate—Loteprednol—Fluoxymesterone—breast cancer	0.0149	0.0394	CrCrCtD
Potassium Canrenoate—Testosterone—Fluoxymesterone—breast cancer	0.014	0.0368	CrCrCtD
Potassium Canrenoate—Prednisolone—Fluoxymesterone—breast cancer	0.0137	0.036	CrCrCtD
Potassium Canrenoate—Hydrocortisone—Fluoxymesterone—breast cancer	0.0131	0.0346	CrCrCtD
Potassium Canrenoate—Fluoxymesterone—PRLR—breast cancer	0.000497	0.145	CrCbGaD
Potassium Canrenoate—Dydrogesterone—PGR—breast cancer	0.000215	0.0626	CrCbGaD
Potassium Canrenoate—Megestrol acetate—PGR—breast cancer	0.000129	0.0377	CrCbGaD
Potassium Canrenoate—Testosterone Propionate—CYP17A1—breast cancer	0.000128	0.0372	CrCbGaD
Potassium Canrenoate—Drospirenone—PGR—breast cancer	0.000113	0.0329	CrCbGaD
Potassium Canrenoate—Testosterone Propionate—COMT—breast cancer	0.000104	0.0303	CrCbGaD
Potassium Canrenoate—Flatulence—Irinotecan—breast cancer	0.000103	0.00132	CcSEcCtD
Potassium Canrenoate—Infection—Vinorelbine—breast cancer	0.000102	0.00132	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Fluorouracil—breast cancer	0.000102	0.00132	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Vinblastine—breast cancer	0.000102	0.00132	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vinblastine—breast cancer	0.000101	0.00131	CcSEcCtD
Potassium Canrenoate—Hyperkalaemia—Doxorubicin—breast cancer	0.000101	0.0013	CcSEcCtD
Potassium Canrenoate—Pain—Melphalan—breast cancer	0.000101	0.0013	CcSEcCtD
Potassium Canrenoate—Nausea—Raloxifene—breast cancer	9.93e-05	0.00128	CcSEcCtD
Potassium Canrenoate—Nausea—Idarubicin—breast cancer	9.93e-05	0.00128	CcSEcCtD
Potassium Canrenoate—Confusional state—Thiotepa—breast cancer	9.93e-05	0.00128	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Tamoxifen—breast cancer	9.86e-05	0.00127	CcSEcCtD
Potassium Canrenoate—Pain—Goserelin—breast cancer	9.85e-05	0.00127	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Paclitaxel—breast cancer	9.81e-05	0.00126	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vinblastine—breast cancer	9.81e-05	0.00126	CcSEcCtD
Potassium Canrenoate—Infection—Thiotepa—breast cancer	9.79e-05	0.00126	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Paclitaxel—breast cancer	9.76e-05	0.00126	CcSEcCtD
Potassium Canrenoate—Asthenia—Chlorambucil—breast cancer	9.72e-05	0.00125	CcSEcCtD
Potassium Canrenoate—Hypotension—Vinorelbine—breast cancer	9.64e-05	0.00124	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Capecitabine—breast cancer	9.6e-05	0.00123	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Tamoxifen—breast cancer	9.53e-05	0.00123	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Goserelin—breast cancer	9.49e-05	0.00122	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Goserelin—breast cancer	9.42e-05	0.00121	CcSEcCtD
Potassium Canrenoate—Phlebitis—Epirubicin—breast cancer	9.37e-05	0.00121	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Chlorambucil—breast cancer	9.27e-05	0.00119	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Vinorelbine—breast cancer	9.26e-05	0.00119	CcSEcCtD
Potassium Canrenoate—Drospirenone—AR—breast cancer	9.26e-05	0.027	CrCbGaD
Potassium Canrenoate—Body temperature increased—Goserelin—breast cancer	9.1e-05	0.00117	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Goserelin—breast cancer	9.1e-05	0.00117	CcSEcCtD
Potassium Canrenoate—Asthenia—Vinblastine—breast cancer	8.9e-05	0.00115	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Thiotepa—breast cancer	8.84e-05	0.00114	CcSEcCtD
Potassium Canrenoate—Pain—Vinorelbine—breast cancer	8.82e-05	0.00113	CcSEcCtD
Potassium Canrenoate—Discomfort—Mitoxantrone—breast cancer	8.77e-05	0.00113	CcSEcCtD
Potassium Canrenoate—Discomfort—Irinotecan—breast cancer	8.77e-05	0.00113	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Paclitaxel—breast cancer	8.72e-05	0.00112	CcSEcCtD
Potassium Canrenoate—Fludrocortisone—AR—breast cancer	8.72e-05	0.0254	CrCbGaD
Potassium Canrenoate—Phlebitis—Doxorubicin—breast cancer	8.67e-05	0.00112	CcSEcCtD
Potassium Canrenoate—Asthenia—Tamoxifen—breast cancer	8.65e-05	0.00111	CcSEcCtD
Potassium Canrenoate—Vomiting—Chlorambucil—breast cancer	8.61e-05	0.00111	CcSEcCtD
Potassium Canrenoate—Confusional state—Irinotecan—breast cancer	8.58e-05	0.0011	CcSEcCtD
Potassium Canrenoate—Confusional state—Mitoxantrone—breast cancer	8.58e-05	0.0011	CcSEcCtD
Potassium Canrenoate—Discomfort—Gemcitabine—breast cancer	8.54e-05	0.0011	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Vinorelbine—breast cancer	8.5e-05	0.00109	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vinblastine—breast cancer	8.49e-05	0.00109	CcSEcCtD
Potassium Canrenoate—Asthenia—Melphalan—breast cancer	8.47e-05	0.00109	CcSEcCtD
Potassium Canrenoate—Infection—Mitoxantrone—breast cancer	8.45e-05	0.00109	CcSEcCtD
Potassium Canrenoate—Infection—Irinotecan—breast cancer	8.45e-05	0.00109	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Vinorelbine—breast cancer	8.43e-05	0.00109	CcSEcCtD
Potassium Canrenoate—Pain—Thiotepa—breast cancer	8.42e-05	0.00108	CcSEcCtD
Potassium Canrenoate—Discomfort—Fluorouracil—breast cancer	8.4e-05	0.00108	CcSEcCtD
Potassium Canrenoate—Flatulence—Paclitaxel—breast cancer	8.38e-05	0.00108	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Docetaxel—breast cancer	8.32e-05	0.00107	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Docetaxel—breast cancer	8.28e-05	0.00106	CcSEcCtD
Potassium Canrenoate—Asthenia—Goserelin—breast cancer	8.26e-05	0.00106	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Tamoxifen—breast cancer	8.25e-05	0.00106	CcSEcCtD
Potassium Canrenoate—Infection—Gemcitabine—breast cancer	8.23e-05	0.00106	CcSEcCtD
Potassium Canrenoate—Confusional state—Fluorouracil—breast cancer	8.21e-05	0.00106	CcSEcCtD
Potassium Canrenoate—Fluoxymesterone—SHBG—breast cancer	8.21e-05	0.0239	CrCbGaD
Potassium Canrenoate—Body temperature increased—Vinorelbine—breast cancer	8.15e-05	0.00105	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Vinorelbine—breast cancer	8.15e-05	0.00105	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Thiotepa—breast cancer	8.12e-05	0.00104	CcSEcCtD
Potassium Canrenoate—Infection—Fluorouracil—breast cancer	8.09e-05	0.00104	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Melphalan—breast cancer	8.08e-05	0.00104	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Thiotepa—breast cancer	8.05e-05	0.00104	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Capecitabine—breast cancer	8.05e-05	0.00104	CcSEcCtD
Potassium Canrenoate—Nausea—Chlorambucil—breast cancer	8.04e-05	0.00104	CcSEcCtD
Potassium Canrenoate—Spironolactone—PGR—breast cancer	8.04e-05	0.0234	CrCbGaD
Potassium Canrenoate—Haemorrhage—Capecitabine—breast cancer	8.01e-05	0.00103	CcSEcCtD
Potassium Canrenoate—Hypotension—Irinotecan—breast cancer	7.95e-05	0.00102	CcSEcCtD
Potassium Canrenoate—Hypotension—Mitoxantrone—breast cancer	7.95e-05	0.00102	CcSEcCtD
Potassium Canrenoate—Vomiting—Vinblastine—breast cancer	7.89e-05	0.00102	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Goserelin—breast cancer	7.88e-05	0.00101	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Thiotepa—breast cancer	7.79e-05	0.001	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Thiotepa—breast cancer	7.79e-05	0.001	CcSEcCtD
Potassium Canrenoate—Testosterone Propionate—AR—breast cancer	7.77e-05	0.0226	CrCbGaD
Potassium Canrenoate—Hypotension—Gemcitabine—breast cancer	7.74e-05	0.000996	CcSEcCtD
Potassium Canrenoate—Drospirenone—BCHE—breast cancer	7.73e-05	0.0225	CrCbGaD
Potassium Canrenoate—Cardiac arrest—Epirubicin—breast cancer	7.67e-05	0.000987	CcSEcCtD
Potassium Canrenoate—Vomiting—Tamoxifen—breast cancer	7.67e-05	0.000986	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Mitoxantrone—breast cancer	7.64e-05	0.000983	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Irinotecan—breast cancer	7.64e-05	0.000983	CcSEcCtD
Potassium Canrenoate—Hypotension—Fluorouracil—breast cancer	7.61e-05	0.000979	CcSEcCtD
Potassium Canrenoate—Rash—Tamoxifen—breast cancer	7.6e-05	0.000978	CcSEcCtD
Potassium Canrenoate—Dermatitis—Tamoxifen—breast cancer	7.59e-05	0.000977	CcSEcCtD
Potassium Canrenoate—Medroxyprogesterone Acetate—PGR—breast cancer	7.54e-05	0.0219	CrCbGaD
Potassium Canrenoate—Spironolactone—SHBG—breast cancer	7.52e-05	0.0219	CrCbGaD
Potassium Canrenoate—Vomiting—Melphalan—breast cancer	7.51e-05	0.000966	CcSEcCtD
Potassium Canrenoate—Rash—Melphalan—breast cancer	7.44e-05	0.000958	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Gemcitabine—breast cancer	7.44e-05	0.000957	CcSEcCtD
Potassium Canrenoate—Dermatitis—Melphalan—breast cancer	7.44e-05	0.000957	CcSEcCtD
Potassium Canrenoate—Asthenia—Vinorelbine—breast cancer	7.4e-05	0.000952	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Docetaxel—breast cancer	7.39e-05	0.000951	CcSEcCtD
Potassium Canrenoate—Nausea—Vinblastine—breast cancer	7.37e-05	0.000948	CcSEcCtD
Potassium Canrenoate—Vomiting—Goserelin—breast cancer	7.32e-05	0.000942	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Fluorouracil—breast cancer	7.32e-05	0.000941	CcSEcCtD
Potassium Canrenoate—Pain—Irinotecan—breast cancer	7.27e-05	0.000936	CcSEcCtD
Potassium Canrenoate—Pain—Mitoxantrone—breast cancer	7.27e-05	0.000936	CcSEcCtD
Potassium Canrenoate—Rash—Goserelin—breast cancer	7.26e-05	0.000934	CcSEcCtD
Potassium Canrenoate—Dermatitis—Goserelin—breast cancer	7.25e-05	0.000933	CcSEcCtD
Potassium Canrenoate—Fluoxymesterone—AR—breast cancer	7.2e-05	0.021	CrCbGaD
Potassium Canrenoate—Nausea—Tamoxifen—breast cancer	7.16e-05	0.000921	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Capecitabine—breast cancer	7.16e-05	0.000921	CcSEcCtD
Potassium Canrenoate—Discomfort—Paclitaxel—breast cancer	7.15e-05	0.00092	CcSEcCtD
Potassium Canrenoate—Abdominal discomfort—Methotrexate—breast cancer	7.14e-05	0.000919	CcSEcCtD
Potassium Canrenoate—Cardiac arrest—Doxorubicin—breast cancer	7.1e-05	0.000913	CcSEcCtD
Potassium Canrenoate—Pain—Gemcitabine—breast cancer	7.09e-05	0.000912	CcSEcCtD
Potassium Canrenoate—Asthenia—Thiotepa—breast cancer	7.07e-05	0.000909	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Vinorelbine—breast cancer	7.06e-05	0.000908	CcSEcCtD
Potassium Canrenoate—Medroxyprogesterone Acetate—SHBG—breast cancer	7.04e-05	0.0205	CrCbGaD
Potassium Canrenoate—Nausea—Melphalan—breast cancer	7.01e-05	0.000902	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Irinotecan—breast cancer	7.01e-05	0.000902	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Mitoxantrone—breast cancer	7.01e-05	0.000902	CcSEcCtD
Potassium Canrenoate—Confusional state—Paclitaxel—breast cancer	6.99e-05	0.0009	CcSEcCtD
Potassium Canrenoate—Pain—Fluorouracil—breast cancer	6.97e-05	0.000896	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Irinotecan—breast cancer	6.96e-05	0.000895	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Mitoxantrone—breast cancer	6.96e-05	0.000895	CcSEcCtD
Potassium Canrenoate—Infection—Paclitaxel—breast cancer	6.89e-05	0.000887	CcSEcCtD
Potassium Canrenoate—Flatulence—Capecitabine—breast cancer	6.87e-05	0.000884	CcSEcCtD
Potassium Canrenoate—Nausea—Goserelin—breast cancer	6.84e-05	0.00088	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Gemcitabine—breast cancer	6.83e-05	0.000878	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Thiotepa—breast cancer	6.74e-05	0.000867	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Mitoxantrone—breast cancer	6.72e-05	0.000865	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Mitoxantrone—breast cancer	6.72e-05	0.000865	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Irinotecan—breast cancer	6.72e-05	0.000865	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Irinotecan—breast cancer	6.72e-05	0.000865	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Fluorouracil—breast cancer	6.71e-05	0.000864	CcSEcCtD
Potassium Canrenoate—Methyltestosterone—SHBG—breast cancer	6.63e-05	0.0193	CrCbGaD
Potassium Canrenoate—Spironolactone—AR—breast cancer	6.59e-05	0.0192	CrCbGaD
Potassium Canrenoate—Vomiting—Vinorelbine—breast cancer	6.56e-05	0.000844	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Gemcitabine—breast cancer	6.55e-05	0.000843	CcSEcCtD
Potassium Canrenoate—Rash—Vinorelbine—breast cancer	6.5e-05	0.000837	CcSEcCtD
Potassium Canrenoate—Dermatitis—Vinorelbine—breast cancer	6.5e-05	0.000836	CcSEcCtD
Potassium Canrenoate—Hypotension—Paclitaxel—breast cancer	6.48e-05	0.000834	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Fluorouracil—breast cancer	6.44e-05	0.000829	CcSEcCtD
Potassium Canrenoate—Vomiting—Thiotepa—breast cancer	6.26e-05	0.000806	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Paclitaxel—breast cancer	6.23e-05	0.000801	CcSEcCtD
Potassium Canrenoate—Rash—Thiotepa—breast cancer	6.21e-05	0.000799	CcSEcCtD
Potassium Canrenoate—Dermatitis—Thiotepa—breast cancer	6.2e-05	0.000798	CcSEcCtD
Potassium Canrenoate—Medroxyprogesterone Acetate—AR—breast cancer	6.18e-05	0.018	CrCbGaD
Potassium Canrenoate—Nausea—Vinorelbine—breast cancer	6.13e-05	0.000788	CcSEcCtD
Potassium Canrenoate—Asthenia—Irinotecan—breast cancer	6.1e-05	0.000785	CcSEcCtD
Potassium Canrenoate—Asthenia—Mitoxantrone—breast cancer	6.1e-05	0.000785	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Methotrexate—breast cancer	6e-05	0.000771	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Methotrexate—breast cancer	5.97e-05	0.000767	CcSEcCtD
Potassium Canrenoate—Asthenia—Gemcitabine—breast cancer	5.94e-05	0.000765	CcSEcCtD
Potassium Canrenoate—Pain—Paclitaxel—breast cancer	5.93e-05	0.000763	CcSEcCtD
Potassium Canrenoate—Confusional state—Docetaxel—breast cancer	5.93e-05	0.000763	CcSEcCtD
Potassium Canrenoate—Progesterone—CYP17A1—breast cancer	5.87e-05	0.0171	CrCbGaD
Potassium Canrenoate—Discomfort—Capecitabine—breast cancer	5.87e-05	0.000755	CcSEcCtD
Potassium Canrenoate—Nausea—Thiotepa—breast cancer	5.85e-05	0.000753	CcSEcCtD
Potassium Canrenoate—Infection—Docetaxel—breast cancer	5.84e-05	0.000752	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Irinotecan—breast cancer	5.82e-05	0.000749	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Mitoxantrone—breast cancer	5.82e-05	0.000749	CcSEcCtD
Potassium Canrenoate—Methyltestosterone—AR—breast cancer	5.81e-05	0.0169	CrCbGaD
Potassium Canrenoate—Confusional state—Capecitabine—breast cancer	5.74e-05	0.000739	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Paclitaxel—breast cancer	5.72e-05	0.000736	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Paclitaxel—breast cancer	5.67e-05	0.00073	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Gemcitabine—breast cancer	5.67e-05	0.000729	CcSEcCtD
Potassium Canrenoate—Infection—Capecitabine—breast cancer	5.66e-05	0.000728	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Epirubicin—breast cancer	5.61e-05	0.000722	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Epirubicin—breast cancer	5.58e-05	0.000718	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Fluorouracil—breast cancer	5.57e-05	0.000717	CcSEcCtD
Potassium Canrenoate—Fluoxymesterone—ESR1—breast cancer	5.55e-05	0.0161	CrCbGaD
Potassium Canrenoate—Hypotension—Docetaxel—breast cancer	5.49e-05	0.000707	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Paclitaxel—breast cancer	5.48e-05	0.000706	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Paclitaxel—breast cancer	5.48e-05	0.000706	CcSEcCtD
Potassium Canrenoate—Vomiting—Mitoxantrone—breast cancer	5.41e-05	0.000696	CcSEcCtD
Potassium Canrenoate—Vomiting—Irinotecan—breast cancer	5.41e-05	0.000696	CcSEcCtD
Potassium Canrenoate—Rash—Irinotecan—breast cancer	5.36e-05	0.00069	CcSEcCtD
Potassium Canrenoate—Rash—Mitoxantrone—breast cancer	5.36e-05	0.00069	CcSEcCtD
Potassium Canrenoate—Dermatitis—Irinotecan—breast cancer	5.36e-05	0.000689	CcSEcCtD
Potassium Canrenoate—Dermatitis—Mitoxantrone—breast cancer	5.36e-05	0.000689	CcSEcCtD
Potassium Canrenoate—Progesterone—ABCC1—breast cancer	5.32e-05	0.0155	CrCbGaD
Potassium Canrenoate—Hypotension—Capecitabine—breast cancer	5.32e-05	0.000684	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Docetaxel—breast cancer	5.28e-05	0.000679	CcSEcCtD
Potassium Canrenoate—Vomiting—Gemcitabine—breast cancer	5.27e-05	0.000678	CcSEcCtD
Potassium Canrenoate—Rash—Gemcitabine—breast cancer	5.22e-05	0.000672	CcSEcCtD
Potassium Canrenoate—Dermatitis—Gemcitabine—breast cancer	5.22e-05	0.000672	CcSEcCtD
Potassium Canrenoate—Haemoglobin—Doxorubicin—breast cancer	5.19e-05	0.000668	CcSEcCtD
Potassium Canrenoate—Vomiting—Fluorouracil—breast cancer	5.18e-05	0.000666	CcSEcCtD
Potassium Canrenoate—Haemorrhage—Doxorubicin—breast cancer	5.17e-05	0.000665	CcSEcCtD
Potassium Canrenoate—Rash—Fluorouracil—breast cancer	5.14e-05	0.000661	CcSEcCtD
Potassium Canrenoate—Dermatitis—Fluorouracil—breast cancer	5.13e-05	0.00066	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Capecitabine—breast cancer	5.11e-05	0.000658	CcSEcCtD
Potassium Canrenoate—Nausea—Irinotecan—breast cancer	5.05e-05	0.00065	CcSEcCtD
Potassium Canrenoate—Nausea—Mitoxantrone—breast cancer	5.05e-05	0.00065	CcSEcCtD
Potassium Canrenoate—Pain—Docetaxel—breast cancer	5.03e-05	0.000647	CcSEcCtD
Potassium Canrenoate—Hydrocortisone—SHBG—breast cancer	4.99e-05	0.0145	CrCbGaD
Potassium Canrenoate—Arrhythmia—Epirubicin—breast cancer	4.99e-05	0.000642	CcSEcCtD
Potassium Canrenoate—Asthenia—Paclitaxel—breast cancer	4.98e-05	0.00064	CcSEcCtD
Potassium Canrenoate—Nausea—Gemcitabine—breast cancer	4.92e-05	0.000633	CcSEcCtD
Potassium Canrenoate—Pain—Capecitabine—breast cancer	4.87e-05	0.000626	CcSEcCtD
Potassium Canrenoate—Methyltestosterone—CYP19A1—breast cancer	4.87e-05	0.0142	CrCbGaD
Potassium Canrenoate—Feeling abnormal—Docetaxel—breast cancer	4.85e-05	0.000623	CcSEcCtD
Potassium Canrenoate—Nausea—Fluorouracil—breast cancer	4.84e-05	0.000623	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Docetaxel—breast cancer	4.81e-05	0.000619	CcSEcCtD
Potassium Canrenoate—Flatulence—Epirubicin—breast cancer	4.79e-05	0.000616	CcSEcCtD
Potassium Canrenoate—Medroxyprogesterone Acetate—ESR1—breast cancer	4.76e-05	0.0139	CrCbGaD
Potassium Canrenoate—Diarrhoea—Paclitaxel—breast cancer	4.75e-05	0.000611	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Capecitabine—breast cancer	4.69e-05	0.000604	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Capecitabine—breast cancer	4.66e-05	0.000599	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Docetaxel—breast cancer	4.65e-05	0.000598	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Docetaxel—breast cancer	4.65e-05	0.000598	CcSEcCtD
Potassium Canrenoate—Arrhythmia—Doxorubicin—breast cancer	4.61e-05	0.000594	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Capecitabine—breast cancer	4.5e-05	0.000579	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Capecitabine—breast cancer	4.5e-05	0.000579	CcSEcCtD
Potassium Canrenoate—Flatulence—Doxorubicin—breast cancer	4.43e-05	0.00057	CcSEcCtD
Potassium Canrenoate—Vomiting—Paclitaxel—breast cancer	4.41e-05	0.000568	CcSEcCtD
Potassium Canrenoate—Hydrocortamate—CYP3A4—breast cancer	4.39e-05	0.0128	CrCbGaD
Potassium Canrenoate—Rash—Paclitaxel—breast cancer	4.37e-05	0.000563	CcSEcCtD
Potassium Canrenoate—Dermatitis—Paclitaxel—breast cancer	4.37e-05	0.000562	CcSEcCtD
Potassium Canrenoate—Discomfort—Methotrexate—breast cancer	4.37e-05	0.000562	CcSEcCtD
Potassium Canrenoate—Progesterone—PGR—breast cancer	4.35e-05	0.0127	CrCbGaD
Potassium Canrenoate—Cortisone acetate—CYP3A4—breast cancer	4.32e-05	0.0126	CrCbGaD
Potassium Canrenoate—Confusional state—Methotrexate—breast cancer	4.27e-05	0.00055	CcSEcCtD
Potassium Canrenoate—Asthenia—Docetaxel—breast cancer	4.22e-05	0.000543	CcSEcCtD
Potassium Canrenoate—Infection—Methotrexate—breast cancer	4.21e-05	0.000542	CcSEcCtD
Potassium Canrenoate—Nausea—Paclitaxel—breast cancer	4.12e-05	0.00053	CcSEcCtD
Potassium Canrenoate—Discomfort—Epirubicin—breast cancer	4.09e-05	0.000526	CcSEcCtD
Potassium Canrenoate—Asthenia—Capecitabine—breast cancer	4.08e-05	0.000526	CcSEcCtD
Potassium Canrenoate—Progesterone—SHBG—breast cancer	4.07e-05	0.0118	CrCbGaD
Potassium Canrenoate—Progesterone—CYP1B1—breast cancer	4.07e-05	0.0118	CrCbGaD
Potassium Canrenoate—Diarrhoea—Docetaxel—breast cancer	4.02e-05	0.000518	CcSEcCtD
Potassium Canrenoate—Confusional state—Epirubicin—breast cancer	4e-05	0.000515	CcSEcCtD
Potassium Canrenoate—Hypotension—Methotrexate—breast cancer	3.96e-05	0.00051	CcSEcCtD
Potassium Canrenoate—Infection—Epirubicin—breast cancer	3.94e-05	0.000507	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Capecitabine—breast cancer	3.9e-05	0.000501	CcSEcCtD
Potassium Canrenoate—Testosterone—SHBG—breast cancer	3.85e-05	0.0112	CrCbGaD
Potassium Canrenoate—Testosterone—CYP1B1—breast cancer	3.85e-05	0.0112	CrCbGaD
Potassium Canrenoate—Paraesthesia—Methotrexate—breast cancer	3.81e-05	0.00049	CcSEcCtD
Potassium Canrenoate—Discomfort—Doxorubicin—breast cancer	3.78e-05	0.000487	CcSEcCtD
Potassium Canrenoate—Vomiting—Docetaxel—breast cancer	3.74e-05	0.000481	CcSEcCtD
Potassium Canrenoate—Rash—Docetaxel—breast cancer	3.71e-05	0.000477	CcSEcCtD
Potassium Canrenoate—Hypotension—Epirubicin—breast cancer	3.71e-05	0.000477	CcSEcCtD
Potassium Canrenoate—Dermatitis—Docetaxel—breast cancer	3.7e-05	0.000477	CcSEcCtD
Potassium Canrenoate—Confusional state—Doxorubicin—breast cancer	3.7e-05	0.000476	CcSEcCtD
Potassium Canrenoate—Infection—Doxorubicin—breast cancer	3.65e-05	0.000469	CcSEcCtD
Potassium Canrenoate—Pain—Methotrexate—breast cancer	3.62e-05	0.000466	CcSEcCtD
Potassium Canrenoate—Vomiting—Capecitabine—breast cancer	3.62e-05	0.000466	CcSEcCtD
Potassium Canrenoate—Rash—Capecitabine—breast cancer	3.59e-05	0.000462	CcSEcCtD
Potassium Canrenoate—Dermatitis—Capecitabine—breast cancer	3.59e-05	0.000461	CcSEcCtD
Potassium Canrenoate—Progesterone—AR—breast cancer	3.57e-05	0.0104	CrCbGaD
Potassium Canrenoate—Drospirenone—PTGS2—breast cancer	3.56e-05	0.0104	CrCbGaD
Potassium Canrenoate—Paraesthesia—Epirubicin—breast cancer	3.56e-05	0.000458	CcSEcCtD
Potassium Canrenoate—Nausea—Docetaxel—breast cancer	3.49e-05	0.000449	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Methotrexate—breast cancer	3.49e-05	0.000449	CcSEcCtD
Potassium Canrenoate—Megestrol acetate—ABCB1—breast cancer	3.47e-05	0.0101	CrCbGaD
Potassium Canrenoate—Gastrointestinal pain—Methotrexate—breast cancer	3.47e-05	0.000446	CcSEcCtD
Potassium Canrenoate—Hydrocortisone—ABCG2—breast cancer	3.44e-05	0.01	CrCbGaD
Potassium Canrenoate—Hypotension—Doxorubicin—breast cancer	3.43e-05	0.000441	CcSEcCtD
Potassium Canrenoate—Pain—Epirubicin—breast cancer	3.39e-05	0.000436	CcSEcCtD
Potassium Canrenoate—Nausea—Capecitabine—breast cancer	3.38e-05	0.000435	CcSEcCtD
Potassium Canrenoate—Testosterone—AR—breast cancer	3.37e-05	0.00982	CrCbGaD
Potassium Canrenoate—Body temperature increased—Methotrexate—breast cancer	3.35e-05	0.000431	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Methotrexate—breast cancer	3.35e-05	0.000431	CcSEcCtD
Potassium Canrenoate—Paraesthesia—Doxorubicin—breast cancer	3.3e-05	0.000424	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Epirubicin—breast cancer	3.27e-05	0.000421	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Epirubicin—breast cancer	3.24e-05	0.000417	CcSEcCtD
Potassium Canrenoate—Pain—Doxorubicin—breast cancer	3.14e-05	0.000404	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Epirubicin—breast cancer	3.14e-05	0.000403	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Epirubicin—breast cancer	3.14e-05	0.000403	CcSEcCtD
Potassium Canrenoate—Asthenia—Methotrexate—breast cancer	3.04e-05	0.000391	CcSEcCtD
Potassium Canrenoate—Feeling abnormal—Doxorubicin—breast cancer	3.02e-05	0.000389	CcSEcCtD
Potassium Canrenoate—Gastrointestinal pain—Doxorubicin—breast cancer	3e-05	0.000386	CcSEcCtD
Potassium Canrenoate—Body temperature increased—Doxorubicin—breast cancer	2.9e-05	0.000373	CcSEcCtD
Potassium Canrenoate—Abdominal pain—Doxorubicin—breast cancer	2.9e-05	0.000373	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Methotrexate—breast cancer	2.9e-05	0.000373	CcSEcCtD
Potassium Canrenoate—Asthenia—Epirubicin—breast cancer	2.85e-05	0.000366	CcSEcCtD
Potassium Canrenoate—Testosterone—CYP19A1—breast cancer	2.82e-05	0.00822	CrCbGaD
Potassium Canrenoate—Progesterone—ESR1—breast cancer	2.75e-05	0.008	CrCbGaD
Potassium Canrenoate—Diarrhoea—Epirubicin—breast cancer	2.71e-05	0.000349	CcSEcCtD
Potassium Canrenoate—Vomiting—Methotrexate—breast cancer	2.69e-05	0.000347	CcSEcCtD
Potassium Canrenoate—Rash—Methotrexate—breast cancer	2.67e-05	0.000344	CcSEcCtD
Potassium Canrenoate—Dermatitis—Methotrexate—breast cancer	2.67e-05	0.000343	CcSEcCtD
Potassium Canrenoate—Testosterone—ABCG2—breast cancer	2.65e-05	0.00772	CrCbGaD
Potassium Canrenoate—Asthenia—Doxorubicin—breast cancer	2.63e-05	0.000339	CcSEcCtD
Potassium Canrenoate—Vomiting—Epirubicin—breast cancer	2.52e-05	0.000324	CcSEcCtD
Potassium Canrenoate—Nausea—Methotrexate—breast cancer	2.52e-05	0.000324	CcSEcCtD
Potassium Canrenoate—Diarrhoea—Doxorubicin—breast cancer	2.51e-05	0.000323	CcSEcCtD
Potassium Canrenoate—Rash—Epirubicin—breast cancer	2.5e-05	0.000322	CcSEcCtD
Potassium Canrenoate—Dermatitis—Epirubicin—breast cancer	2.5e-05	0.000321	CcSEcCtD
Potassium Canrenoate—Prednisone—CYP3A4—breast cancer	2.44e-05	0.00711	CrCbGaD
Potassium Canrenoate—Medroxyprogesterone Acetate—CYP3A4—breast cancer	2.43e-05	0.00707	CrCbGaD
Potassium Canrenoate—Nausea—Epirubicin—breast cancer	2.36e-05	0.000303	CcSEcCtD
Potassium Canrenoate—Vomiting—Doxorubicin—breast cancer	2.33e-05	0.0003	CcSEcCtD
Potassium Canrenoate—Rash—Doxorubicin—breast cancer	2.31e-05	0.000298	CcSEcCtD
Potassium Canrenoate—Dermatitis—Doxorubicin—breast cancer	2.31e-05	0.000297	CcSEcCtD
Potassium Canrenoate—Methyltestosterone—CYP3A4—breast cancer	2.29e-05	0.00665	CrCbGaD
Potassium Canrenoate—Prednisolone—CYP3A4—breast cancer	2.25e-05	0.00655	CrCbGaD
Potassium Canrenoate—Progesterone—CYP1A1—breast cancer	2.2e-05	0.0064	CrCbGaD
Potassium Canrenoate—Nausea—Doxorubicin—breast cancer	2.18e-05	0.00028	CcSEcCtD
Potassium Canrenoate—Spironolactone—ABCB1—breast cancer	2.16e-05	0.00628	CrCbGaD
Potassium Canrenoate—Prednisone—ALB—breast cancer	2.13e-05	0.0062	CrCbGaD
Potassium Canrenoate—Testosterone—CYP1A1—breast cancer	2.08e-05	0.00605	CrCbGaD
Potassium Canrenoate—Prednisone—ABCB1—breast cancer	2.03e-05	0.00592	CrCbGaD
Potassium Canrenoate—Methyltestosterone—ALB—breast cancer	1.99e-05	0.0058	CrCbGaD
Potassium Canrenoate—Prednisolone—ABCB1—breast cancer	1.87e-05	0.00545	CrCbGaD
Potassium Canrenoate—Hydrocortisone—CYP3A4—breast cancer	1.72e-05	0.00501	CrCbGaD
Potassium Canrenoate—Progesterone—CYP2D6—breast cancer	1.63e-05	0.00476	CrCbGaD
Potassium Canrenoate—Hydrocortisone—ABCB1—breast cancer	1.43e-05	0.00417	CrCbGaD
Potassium Canrenoate—Progesterone—CYP3A4—breast cancer	1.4e-05	0.00408	CrCbGaD
Potassium Canrenoate—Testosterone—CYP3A4—breast cancer	1.33e-05	0.00386	CrCbGaD
Potassium Canrenoate—Progesterone—ABCB1—breast cancer	1.17e-05	0.0034	CrCbGaD
Potassium Canrenoate—Testosterone—ALB—breast cancer	1.16e-05	0.00337	CrCbGaD
Potassium Canrenoate—Testosterone—ABCB1—breast cancer	1.1e-05	0.00321	CrCbGaD
